STOK: Stoke Therapeutics, Inc. Common Stock Company Profile & Statistics

About

Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.

Info & Links

CEO

Edward M. Kaye

Headquarters

45 WIGGINS AVENUE
BEDFORD, MA 01730, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

128

Stoke Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

395.04M

Enterprise Value

266.98M

Enterprise Value/EBITDA(ttm)

-2.65

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

27.65

Price to Book(mrq)

1.98

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-629.90%

Profit Margin(ttm)

-435.96%

Return on Equity(ttm)

-54.45%

Return on Invested Capital(ttm)

-45.34%

Return on Assets(ttm)

-40.77%

Income Statement

Revenue(ttm)

36.56M

Revenue Per Share(ttm)

0.68

Gross Profit(ttm)

36.56M

EBITDA(ttm)³

-100.84M

Net Income Available to Common(ttm)

-88.98M

Diluted EPS(ttm)

-2.10

Share Statistics

Beta (5Y Monthly)

0.95

52-Week Change

-34.03%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

54.08M

Dividend Yield

0.00%

Float⁴

46.98M

% Held by Insiders

11.30%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

216.97M

Total Cash Per Share(mrq)

4.01

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

5.81%

Quick Ratio(mrq)

5.09%

Book Value Per Share(mrq)

4.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.61

Free Cash Flow(ytd)

-87.05M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

STOK

Stoke Therapeutics, Inc. Common Stock

Stoke Therapeutics, Inc. Common Stock Profile